Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Roelofs PA"" wg kryterium: Autor


Wyświetlanie 1-3 z 3
Tytuł:
Aberrant APOBEC3B Expression in Breast Cancer Is Linked to Proliferation and Cell Cycle Phase.
Autorzy:
Roelofs PA; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, and Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA.
Timmermans MAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Stefanovska B; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, and Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA.; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
den Boestert MA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
van den Borne AWM; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Balcioglu HE; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Trapman AM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Harris RS; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, and Center for Genome Engineering, University of Minnesota, Minneapolis, MN 55455, USA.; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.
Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3000 CA Rotterdam, The Netherlands.
Span PN; Radiotherapy & OncoImmunology Laboratory, Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Apr 18; Vol. 12 (8). Date of Electronic Publication: 2023 Apr 18.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/genetics
Humans ; Female ; Cyclin B1/genetics ; Cell Division ; Cell Cycle/genetics ; MCF-7 Cells ; Cytidine Deaminase/genetics ; Cytidine Deaminase/metabolism ; Minor Histocompatibility Antigens/genetics ; Minor Histocompatibility Antigens/metabolism
Czasopismo naukowe
Tytuł:
Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.
Autorzy:
Roelofs PA; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, United States.; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
Goh CY; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Chua BH; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Jarvis MC; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, United States.
Stewart TA; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, United States.; Mater Research Institute, The University of Queensland, Faculty of Medicine, Brisbane, Australia.
McCann JL; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, United States.; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, United States.
McDougle RM; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, United States.; Hennepin Healthcare, Minneapolis, United States.
Carpenter MA; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, United States.; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, United States.
Martens JW; Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
Span PN; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, Netherlands.
Kappei D; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Harris RS; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, Center for Genome Engineering, University of Minnesota, Minneapolis, United States.; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, United States.
Pokaż więcej
Źródło:
ELife [Elife] 2020 Sep 28; Vol. 9. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Signal Transduction*
Cytidine Deaminase/*genetics
E2F Transcription Factors/*genetics
Minor Histocompatibility Antigens/*genetics
Cytidine Deaminase/metabolism ; E2F Transcription Factors/metabolism ; HEK293 Cells ; Humans ; MCF-7 Cells ; Minor Histocompatibility Antigens/metabolism ; Protein Binding
Czasopismo naukowe
Tytuł:
Polyomavirus T Antigen Induces APOBEC3B Expression Using an LXCXE-Dependent and TP53-Independent Mechanism.
Autorzy:
Starrett GJ; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA.
Serebrenik AA; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA.
Roelofs PA; Department of Radiation Oncology, Radiotherapy and OncoImmunology Laboratory, Radboud University Medical Center, Nijmegen, The Netherlands.
McCann JL; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA.
Verhalen B; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jarvis MC; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA.
Stewart TA; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA.
Law EK; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA.
Krupp A; Department of Neuroimmunology, Biogen, Cambridge, Massachusetts, USA.
Jiang M; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Martens JWM; Department of Medical Oncology, Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.
Cahir-McFarland E; Department of Neuroimmunology, Biogen, Cambridge, Massachusetts, USA.
Span PN; Department of Radiation Oncology, Radiotherapy and OncoImmunology Laboratory, Radboud University Medical Center, Nijmegen, The Netherlands.
Harris RS; Department of Biochemistry, Molecular Biology and Biophysics, Masonic Cancer Center, Institute for Molecular Virology, University of Minnesota, Minneapolis, Minnesota, USA .; Howard Hughes Medical Institute, University of Minnesota, Minneapolis, Minnesota, USA.
Pokaż więcej
Źródło:
MBio [mBio] 2019 Feb 05; Vol. 10 (1). Date of Electronic Publication: 2019 Feb 05.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Host-Pathogen Interactions*
Up-Regulation*
Antigens, Viral, Tumor/*metabolism
Cytidine Deaminase/*biosynthesis
Minor Histocompatibility Antigens/*biosynthesis
Polyomavirus/*growth & development
Tumor Suppressor Protein p53/*metabolism
Antigens, Viral, Tumor/genetics ; Binding Sites ; Cells, Cultured ; E2F Transcription Factors/metabolism ; Gene Expression Profiling ; Humans ; Mutant Proteins/genetics ; Mutant Proteins/metabolism ; Neoplasms/pathology ; Retinoblastoma Binding Proteins/metabolism
Czasopismo naukowe
    Wyświetlanie 1-3 z 3

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies